Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes
Background: Diabetic peripheral neuropathy (DPN), the most common microvascular complication of type-2 diabetes mellitus (T2DM), results in nontraumatic lower-limb amputations. When DPN is not detected early, disease progression is irreversible. Thus, biomarkers for diagnosing DPN are needed. Method...
Guardado en:
Autores principales: | Noo Ree Cho, Yeuni Yu, Chang-Kyu Oh, Dai Sik Ko, Kyungjae Myung, Yoonsung Lee, Hee Sam Na, Yun Hak Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a3da1dc74b347fc96d228c08c8d0645 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Application of Exercise Training for Diabetic Peripheral Neuropathy
por: Clifton J. Holmes, et al.
Publicado: (2021) -
Diabetic Peripheral Neuropathies: A Morphometric Overview
por: Fazan,Valéria Paula Sassoli, et al.
Publicado: (2010) -
Electrodiagnostics or Ultrasound for Diagnosing Diabetic Peripheral Neuropathy [Letter]
por: Hernandez Fustes OJ, et al.
Publicado: (2021) -
Application of High-Resolution Ultrasound on Diagnosing Diabetic Peripheral Neuropathy
por: Huang H, et al.
Publicado: (2021) -
Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy
por: Wu M, et al.
Publicado: (2020)